Wednesday, June 07, 2006

Novartis buy British "bug busters" for half a billion

Novartis AG boosted its infectious diseases portfolio on Wednesday by agreeing to buy British firm NeuTec Pharma, a specialist in fighting hospital superbugs, for nearly $570 million.

More at Reuters

No comments: